CFH, C3 and ARMS2 Are Significant Risk Loci for Susceptibility but Not for Disease Progression of Geographic Atrophy Due to AMD
Open Access
- 12 October 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (10) , e7418
- https://doi.org/10.1371/journal.pone.0007418
Abstract
Age-related macular degeneration (AMD) is a prevalent cause of blindness in Western societies. Variants in the genes encoding complement factor H (CFH), complement component 3 (C3) and age-related maculopathy susceptibility 2 (ARMS2) have repeatedly been shown to confer significant risks for AMD; however, their role in disease progression and thus their potential relevance for interventional therapeutic approaches remains unknown. Here, we analyzed association between variants in CFH, C3 and ARMS2 and disease progression of geographic atrophy (GA) due to AMD. A quantitative phenotype of disease progression was computed based on longitudinal observations by fundus autofluorescence imaging. In a subset of 99 cases with pure bilateral GA, variants in CFH (Y402H), C3 (R102G), and ARMS2 (A69S) are associated with disease (P = 1.6×10−9, 3.2×10−3, and P = 2.6×10−12, respectively) when compared to 612 unrelated healthy control individuals. In cases, median progression rate of GA over a mean follow-up period of 3.0 years was 1.61 mm2/year with high concordance between fellow eyes. No association between the progression rate and any of the genetic risk variants at the three loci was observed (P>0.13). This study confirms that variants at CFH, C3, and ARMS2 confer significant risks for GA due to AMD. In contrast, our data indicate no association of these variants with disease progression which may have important implications for future treatment strategies. Other, as yet unknown susceptibilities may influence disease progression.Keywords
This publication has 45 references indexed in Scilit:
- Systemic Complement Activation in Age-Related Macular DegenerationPLOS ONE, 2008
- Age-Related Macular DegenerationNew England Journal of Medicine, 2008
- Likelihood-Based Association Analysis for Nuclear Families and Unrelated Subjects with Missing Genotype DataHuman Heredity, 2008
- A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degenerationProceedings of the National Academy of Sciences, 2007
- Variation in complement factor 3 is associated with risk of age-related macular degenerationNature Genetics, 2007
- Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epitheliumProceedings of the National Academy of Sciences, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- CFH Y402H Confers Similar Risk of Soft Drusen and Both Forms of Advanced AMDPLoS Medicine, 2005
- Complement Factor H Polymorphism in Age-Related Macular DegenerationScience, 2005
- Inhibition of the ATP‐driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2‐E may contribute to the pathogenesis of age‐related macular degenerationThe FASEB Journal, 2004